ArticleMolecular oncology2020
In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Jeremy Ariey-Bonnet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it